Author Search Results

Eneida A. Mendonça

Eneida A. Mendonça, is a Brazilian-born physician-scientist and biomedical informatician. She pioneered the use of natural language processing in both the biomedical literature and in electronic medical record narratives in order to identify knowledge relevant to medical decision making in the context of the patient care. In addition, she has devoted many years to develop innovative clinical information systems that have been integrated in the NewYork–Presbyterian Hospital, the Columbia University Medical Center, and the Cornell Medical Center. She holds a medical degree from the Federal University of Pelotas, Brazil and a Ph.D. in biomedical informatics from Columbia University, New York.

Currently, Mendonça is the Inaugural VP for Research Development of the Regenstrief Institute at the Indiana University School of Medicine. Mendonça has contributed over 100 publications to the fields of biomedical informatics and medicine. Provided by Wikipedia

1

Conflicting biomedical assumptions for mathematical modeling: the case of cancer metastasis.

by Anna Divoli, Eneida A Mendonça, James A Evans, Andrey Rzhetsky
Published 2011-10-01

Get full text

Article
2

Development and validation of a pragmatic natural language processing approach to identifying falls in older adults in the emergency department

by Brian W. Patterson, Gwen C. Jacobsohn, Manish N. Shah, Yiqiang Song, Apoorva Maru, Arjun K. Venkatesh, Monica Zhong, Katherine Taylor, Azita G. Hamedani, Eneida A. Mendonça
Published 2019-07-01

Get full text

Article
3

Determinants of Long Immunization Clinic Wait Times in a Sub-Saharan African Country

by Osayame Austine Ekhaguere MBBS, MPH, Rosena Olubanke Oluwafemi MBChB, MPH, Angela Oyo-Ita MBBS, MPH, Burke Mamlin MD, Paul Bondich MD, MS, Eneida A. Mendonca MD, PhD, Angela L. Rollins PhD
Published 2021-06-01

Get full text

Article
4

MD-CTS: An integrated terminology reference of clinical and translational medicine

by Will Ray, Joe Finamore, Majid Rastegar-Mojarad, Chris Kadolph, Zhan Ye, Jacquie Bohne, Yin Xu, Dan Burish, Joshua Sondelski, Melissa Easker, Brian Finnegan, Barbara Bartkowiak, Catherine Arnott Smith, Umberto Tachinardi, Eneida A. Mendonca, Bryan Weichelt, Simon M. Lin
Published 2016-01-01

Get full text

Article
5

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab

by Amy K. Erbe, Wei Wang, Lakeesha Carmichael, Anna Hoefges, Bartosz Grzywacz, Patrick K. Reville, Erik A. Ranheim, Jacquelyn A. Hank, KyungMann Kim, Songwon Seo, Eneida A. Mendonca, Yiqiang Song, Vaishalee P. Kenkre, Fangxin Hong, Randy D. Gascoyne, Elisabeth Paietta, Sandra J. Horning, Jeffrey S. Miller, Brad Kahl, Paul M. Sondel
Published 2019-03-01

Get full text

Article
6

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

by Amy K. Erbe, Wei Wang, Patrick K. Reville, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonca, Yiqiang Song, Jacquelyn A. Hank, Wendy B. London, Arlene Naranjo, Fangxin Hong, Michael D. Hogarty, John M. Maris, Julie R. Park, Julie R. Park, M. F. Ozkaynak, Jeffrey S. Miller, Andrew L. Gilman, Brad Kahl, Alice L. Yu, Alice L. Yu, Paul M. Sondel, Paul M. Sondel
Published 2017-06-01

Get full text

Article